Home / Noggin / Recombinant Human Noggin Fc Chimera Protein, CF

Recombinant Human Noggin Fc Chimera Protein, CF

Catalog #: 3344-NG
21 Citations Datasheet / COA / SDS
Catalog # Availability Size / Price Qty
3344-NG-050
3344-NG-500
3344-NG-100

Purchase Cultrex™ BME with Select Proteins and Save 15% Using Promo Code: PROTBME15. Purchase a select BME product from our catalog along with a minimum of one select growth factor or matrix-regulating protein and receive 15% off your order using promo code: PROTBME15. See offer details for additional qualifying products and terms and conditions.

Graph showing bioactivity of human Noggin protein
1 Image
Product Details
Citations (21)
FAQs
Supplemental Products
Reviews
Summary Product Datasheets Carrier Free Data Images Reconstitution Calculator Background Related Research Areas

Recombinant Human Noggin Fc Chimera Protein, CF Summary

Product Specifications

Purity
>90%, by SDS-PAGE under reducing conditions and visualized by silver stain.
Endotoxin Level
<0.10 EU per 1 μg of the protein by the LAL method.
Activity
Measured by its ability to inhibit BMP-4-induced alkaline phosphatase production by ATDC5 mouse chondrogenic cells. The ED50 for this effect is 0.100-0.400 µg/mL in the presence of 30 ng/mL of Recombinant Human BMP‑4 (Catalog # 314-BP).
Source
Mouse myeloma cell line, NS0-derived human Noggin protein
Human Noggin
(Gln28-Cys232)
Accession # Q13253		 IEGRMD Human IgG1
(Pro100-Lys330)
N-terminus C-terminus
Accession #
Q13253
N-terminal Sequence
Analysis
No results obtained: Gln28 predicted
Structure / Form
Disulfide-linked homodimer
Predicted Molecular Mass
49.6 kDa (monomer)
SDS-PAGE
58-62 kDa, reducing conditions

Product Datasheets

You must select a language.

x

3344-NG

Product Datasheet
COA
SDS

Carrier Free

What does CF mean?

CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.

What formulation is right for me?

In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.

3344-NG

Formulation Lyophilized from a 0.2 μm filtered solution in PBS.
Reconstitution Reconstitute at 100 μg/mL in sterile PBS.
Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 3 months, -20 to -70 °C under sterile conditions after reconstitution.

Scientific Data

Bioactivity Graph showing bioactivity of human Noggin protein View Larger

Recombinant human Noggin Fc chimera (3344-NG) inhibits recombinant human BMP-4-induced alkaline phosphatase production in the ATDC5 mouse chondrogenic cell line. The ED50 for this effect is 0.100-0.400 µg/mL in the presence of 30 ng/mL of recombinant human BMP-4 (314-BP).

Reconstitution Calculator

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Background: Noggin

Noggin is a secreted homodimeric glycoprotein that is an antagonist of bone morphogenetic proteins (BMPs) (1, 2). Human Noggin cDNA encodes a 232 amino acid (aa) precursor protein; cleavage of a 19 aa signal peptide generates the 213 aa mature protein which contains an N-terminal acidic region, a central basic heparin‑binding segment and a C-terminal cysteine-knot structure (2). Secreted Noggin probably remains close to the cell surface due to its binding of heparin‑containing proteoglycans (3). Noggin is very highly conserved among vertebrates, such that mature human Noggin shares 99%, 99%, 98%, 97% and 89% aa sequence identity with mouse, rat, bovine, equine and chicken Noggin, respectively. Noggin binds some BMPs such as BMP-4 with high affinity and others such as BMP-7 with lower affinity, antagonizing BMP bioactivities by blocking epitopes on BMPs that are needed for binding to both type I and type II receptors (2, 4). 

During embryogenesis, Noggin antagonizes specific BMPs at defined times during neural tube, somite and cardiomyocyte growth and patterning (5-7). During skeletal development, Noggin prevents chondrocyte hyperplasia, thus allowing proper formation of joints (4). Mutations within the cysteine-knot region of human Noggin are linked to multiple types of skeletal dysplasias that result in apical joint fusions (8). Noggin is expressed in defined areas of the adult central nervous system and peripheral tissues such as lung, skeletal muscle and skin (1). During culture of human embryonic stem cells (hESC) without feeder layers or conditioned medium, but with addition of FGF basic, addition of Noggin to antagonize BMP activity allows hESC to maintain their undifferentiated, pluripotent state (9, 10). In differentiation protocols, Noggin has been used to create neural crest stem cells from induced pluripotent stem cells (11). 

Because of its importance in the development of tissues, regenerative medicine utilizes Noggin to generate cells for intestinal tissues or organoids in vitro (12). Noggin is also an important factor for stimulating bone development and has neuroprotective effects in early stages of spinal cord injury (13, 14). Expression of Noggin can help contain or reduce metastatic lesions by limiting BMP signaling, making it a therapeutic option for cancer treatment (15). Noggin has been used to create bladder cancer organoids that can serve as a tissue model in preclinical testing of chimeric antigen receptor (CAR)-T-cell immunotherapy (16).

References
  1. Valenzuela, D.M. et al. (1995) J. Neurosci. 15:6077.
  2. Groppe, J. et al. (2002) Nature 420:636.
  3. Paine-Saunders, S et al. (2002) J. Biol. Chem. 277:2089.
  4. Brunet, L. J. et al. (1998) Science 280:1455.
  5. McMahon, J. A. et al. (1998) Genes Dev. 12:1438.
  6. Itsykson, P. et al. (2005) Mol. Cell. Neurosci. 30:24.
  7. Yuasa, S. et al. (2005) Nat. Biotechnol. 23:607.
  8. Gong, Y. et al. (1999) Nat. Genet. 21:302.
  9. Xu, R.-H. et al. (2005) Nat. Methods 2:185.
  10. Wang, G. et al. (2005) Biochem. Biophys. Res. Commun. 330:934.
  11. Abe, R. et al. (2021) J. Rural. Med. 16:143.
  12. Kim, S. et al. (2022) Nat. Commu. 13:1692.
  13. Malijauskaite, S. et al. (2021) Cytokines Growth Factor Rev. 60:76.
  14. Al-Sammarraie, N. et al. (2022) Neural Regen Res. 18:492.
  15. Davis, H. et al. (2016) Cytokines Growth Factor Rev. 27:81.
  16. Yu, L. et al. (2021) Clin. Transl. Immunology 10:e1248.
Entrez Gene IDs
9241 (Human); 18121 (Mouse)
Alternate Names
NOG; Noggin; SYM1; symphalangism 1 (proximal); synostoses (multiple) syndrome 1; SYNS1; SYNS1A

Citations for Recombinant Human Noggin Fc Chimera Protein, CF

R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.

21 Citations: Showing 1 - 10
Filter your results:

Filter by:

  1. SHOX2 refines the identification of human sinoatrial nodal cell population in the in�vitro cardiac differentiation
    Authors: T Wakimizu, K Morikawa, K Fukumura, T Yuki, T Adachi, Y Kurata, J Miake, I Hisatome, M Tsuneto, Y Shirayoshi
    Regenerative Therapy, 2022;21(0):239-249.
    Species: Human
    Sample Types: Transfected Whole Cells
    Applications: Bioassay
  2. Modeling human multi-lineage heart field development with pluripotent stem cells
    Authors: D Yang, J Gomez-Garc, S Funakoshi, T Tran, I Fernandes, GD Bader, MA Laflamme, GM Keller
    Cell Stem Cell, 2022;29(9):1382-1401.e8.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  3. Oligodendrocyte differentiation alters tRNA modifications and codon optimality-mediated mRNA decay
    Authors: S Martin, KC Allan, O Pinkard, T Sweet, PJ Tesar, J Coller
    Nature Communications, 2022;13(1):5003.
    Species: Mouse
    Sample Types: Whole Cells
    Applications: Bioassay
  4. Microvessels support engraftment and functionality of human islets and hESC-derived pancreatic progenitors in diabetes models
    Authors: Y Aghazadeh, F Poon, F Sarangi, FTM Wong, ST Khan, X Sun, R Hatkar, BJ Cox, SS Nunes, MC Nostro
    Cell Stem Cell, 2021;0(0):.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  5. Non-canonical Targets of HIF1a Impair Oligodendrocyte Progenitor Cell Function
    Authors: KC Allan, LR Hu, MA Scavuzzo, AR Morton, AS Gevorgyan, EF Cohn, BLL Clayton, IR Bederman, S Hung, CF Bartels, M Madhavan, PJ Tesar
    Cell Stem Cell, 2020;0(0):.
    Species: Mouse
    Sample Types: Whole Cells
    Applications: Bioassay
  6. Reprogramming of Fibroblasts to Oligodendrocyte Progenitor-like Cells Using CRISPR/Cas9-Based Synthetic Transcription Factors
    Authors: M Matjusaiti, LJ Wagstaff, A Martella, B Baranowski, C Blin, S Gogolok, A Williams, SM Pollard
    Stem Cell Reports, 2019;13(6):1053-1067.
    Species: Mouse
    Sample Types: Whole Cells
    Applications: Cell Culture
  7. Differentiation of Retinal Glial Cells From Human Embryonic Stem Cells by Promoting the Notch Signaling Pathway
    Authors: SH Chung, W Shen, KC Davidson, A Pébay, RCB Wong, B Yau, M Gillies
    Front Cell Neurosci, 2019;13(0):527.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  8. Lineage commitment of embryonic cells involves MEK1-dependent clearance of pluripotency regulator Ventx2
    Authors: P Scerbo, L Marchal, L Kodjabachi
    Elife, 2017;6(0):.
    Species: Xenopus
    Sample Types: In Vivo
    Applications: In Vivo
  9. BMP4 Signaling Is Able to Induce an Epithelial-Mesenchymal Transition-Like Phenotype in Barrett's Esophagus and Esophageal Adenocarcinoma through Induction of SNAIL2.
    Authors: Christine Kestens, Peter D Siersema, G Johan A Offerhaus, Jantine W P M Van Baal
    PLoS ONE, 2016;0(0):1932-6203.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  10. Modulation of stemness in a human normal intestinal epithelial crypt cell line by activation of the WNT signaling pathway.
    Authors: Guezguez A, Pare F, Benoit Y, Basora N, Beaulieu J
    Exp Cell Res, 2014;322(2):355-64.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  11. Generation of glucose-responsive, insulin-producing cells from human umbilical cord blood-derived mesenchymal stem cells.
    Authors: Prabakar K, Dominguez-Bendala J, Molano R, Pileggi A, Villate S, Ricordi C, Inverardi L
    Cell Transplant, 2012;21(6):1321-39.
    Species: Human
    Sample Types: Whole Cells
    Applications: Cell Culture
  12. Cell-surface markers for the isolation of pancreatic cell types derived from human embryonic stem cells.
    Authors: Kelly OG, Chan MY, Martinson LA
    Nat. Biotechnol., 2011;29(8):750-6.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  13. Vitronectin promotes oligodendrocyte differentiation during neurogenesis of human embryonic stem cells.
    Authors: Gil JE, Woo DH, Shim JH, Kim SE, You HJ, Park SH, Paek SH, Kim SK, Kim JH
    FEBS Lett., 2009;583(3):561-7.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  14. Signaling hierarchy regulating human endothelial cell development.
    Authors: Kelly MA, Hirschi KK
    Arterioscler. Thromb. Vasc. Biol., 2009;29(5):718-24.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  15. Human ES cell-derived neural rosettes reveal a functionally distinct early neural stem cell stage.
    Authors: Elkabetz Y, Panagiotakos G, Al Shamy G, Socci ND, Tabar V, Studer L
    Genes Dev., 2008;22(2):152-65.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  16. High-density lipoproteins affect endothelial BMP-signaling by modulating expression of the activin-like kinase receptor 1 and 2.
    Authors: Yao Y, Shao ES, Jumabay M, Shahbazian A, Ji S, Bostrom KI
    Arterioscler. Thromb. Vasc. Biol., 2008;28(12):2266-74.
    Species: Bovine
    Sample Types: Whole Cells
    Applications: Bioassay
  17. Thalidomide induces limb deformities by perturbing the Bmp/Dkk1/Wnt signaling pathway.
    Authors: Knobloch J, Shaughnessy JD, Ruther U
    FASEB J., 2007;21(7):1410-21.
    Species: Chicken
    Sample Types: In Vivo
    Applications: In Vivo
  18. Activin a efficiently specifies definitive endoderm from human embryonic stem cells only when phosphatidylinositol 3-kinase signaling is suppressed.
    Authors: McLean AB, D&amp;amp;apos;Amour KA, Jones KL, Krishnamoorthy M, Kulik MJ, Reynolds DM, Sheppard AM, Liu H, Xu Y, Baetge EE, Dalton S
    Stem Cells, 2007;25(1):29-38.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  19. BMP gradients steer nerve growth cones by a balancing act of LIM kinase and Slingshot phosphatase on ADF/cofilin.
    Authors: Wen Z, Han L, Bamburg JR, Shim S, Ming GL, Zheng JQ
    J. Cell Biol., 2007;178(1):107-19.
    Species: Xenopus
    Sample Types: Whole Cells
    Applications: Bioassay
  20. Multipotent adult progenitor cells from swine bone marrow.
    Authors: Zeng L, Rahrmann E, Hu Q, Lund T, Sandquist L, Felten M, O'Brien TD, O'Brien TD, Zhang J, Verfaillie C
    Stem Cells, 2006;24(11):2355-66.
    Species: Porcine
    Sample Types: Whole Cells
    Applications: Bioassay
  21. BMPs restrict the position of premuscle masses in the limb buds by influencing Tcf4 expression.
    Authors: Bonafede A, Kohler T, Rodriguez-Niedenfuhr M, Brand-Saberi B
    Dev. Biol., 2006;299(2):330-44.
    Species: Chicken
    Sample Types: In Ovo
    Applications: In Ovo

FAQs

No product specific FAQs exist for this product, however you may

View all Proteins and Enzyme FAQs

Animal-Free Recombinant Proteins

Recombinant Human EGF, Animal-Free Protein

AFL236
5 Citations
BA

Basement Membrane Extracts

Cultrex Reduced Growth Factor Basement Membrane Extract, Type 2, Pathclear

3533-010-02
36 Citations
5 Reviews
6 Images

GMP Recombinant Proteins

Recombinant Human EGF GMP Protein, CF

236-GMP
1 Citations
2 Reviews
3 Images
BA

Recombinant Human Noggin Fc Chimera GMP Protein, CF

3344-GMP
2 Images
BA

Recombinant Human Noggin GMP Protein, CF

6057-GMP
1 Review
2 Images
BA

Recombinant Human Wnt-3a GMP Protein, CF

5036-GMP
1 Citations
2 Images
BA,BA

Recombinant Proteins

Recombinant Human EGF Protein, CF

236-EG
684 Citations
27 Reviews
2 Images
BA

Recombinant Human FGF-10 Protein

345-FG
84 Citations
1 Review
2 Images
BA

Recombinant Human Noggin Protein

6057-NG
174 Citations
8 Reviews
3 Images
BA

Recombinant Human Wnt-3a (High Purity) Protein

5036-WNP
4 Citations
2 Images
BA,BA

Recombinant Human Wnt-3a Protein

5036-WN
324 Citations
24 Reviews
2 Images
BA,BA

Tocris Peptides

Gastrin I (human)

3006
9 Citations
1 Review
1 Image

Tocris Small Molecules

Y-27632 dihydrochloride

1254
250 Citations
15 Reviews
1 Image

Reviews for Recombinant Human Noggin Fc Chimera Protein, CF

There are currently no reviews for this product. Be the first to review Recombinant Human Noggin Fc Chimera Protein, CF and earn rewards!

Have you used Recombinant Human Noggin Fc Chimera Protein, CF?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review